Exoskeleton Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 0.82 Billion |
| Market Size (2029) | USD 2.79 Billion |
| CAGR (2024 - 2029) | 15.32 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Exoskeleton Market Analysis
The Global Exoskeleton Market size is estimated at USD 0.82 billion in 2024, and is expected to reach USD 2.79 billion by 2029, growing at a CAGR of 15.32% during the forecast period (2024-2029).
The major factors propelling the market’s growth are the high burden of stroke, the increasing adoption of exoskeletons, and the growing geriatric population. With the increasing number of disabled and aged people, the demand for robotic rehabilitation is rising globally.
In recent years, the demand for physical therapy services has grown, partly because of the aging population. The role of technology in healthcare has become evident with the enhanced rate of survival from medical disorders such as stroke. Robotic rehabilitation and assistive technologies ease the stress on the physiotherapy staff and control expenses while refining patients’ quality of life.
The higher burden of musculoskeletal injuries, mainly spinal cord injuries, is projected to augment the adoption of exoskeleton systems as a rehabilitation system after spinal cord injuries. For instance, according to a May 2023 report of Spinal Cord Inc., around 18,000 spinal cord injuries (SCI) were reported every year in the United States, with an annual incidence rate of 54 per 1 million. Similarly, according to an article published by Springer Nature in November 2023, the burden of spondylodiscitis increased in Germany over the years and is more prevalent in the elderly population. Thus, the exaggerated burden of spinal cord injuries is likely to present lucrative growth opportunities for exoskeleton systems to offer ergonomic support for the body, which is anticipated to boost market growth over the forecast period.
The proven role of modern exoskeleton systems in the rehabilitation of spinal cord injuries is another factor projected to boost market growth over the forecast period. According to an article published by the Journal of Neuro Engineering and Rehabilitation in March 2023, the adoption of exoskeleton systems in clinical settings is safe and well-tolerated by patients, and patients receiving exoskeleton systems as a rehabilitation therapy after spinal cord injuries reported walking independence with these systems. Thus, the profound role of these systems is projected to boost their adoption over the coming years.
Innovations through key market players and increasing regulatory sanctions are also projected to foster market expansion. For instance, in October 2022, Kenoteq, a Heriot-Watt spin-out company, participated in a trial to test the capacity of exoskeleton suits in a factory environment.
In addition, in April 2023, Harmonic Bionics launched its flagship exoskeleton, Harmony SHR, following registration with the US FDA. Thus, such participations are poised to offer significant promise for the development of advanced exoskeleton systems, which is expected to boost market growth over the forecast period.
Thus, growing demand from the healthcare sector for robotic rehabilitation, high incidence of spinal cord injuries, advancement in robotic technologies, and huge investments in the development of exoskeleton technology are expected to drive market growth over the forecast period. However, the risks involved in using exoskeletons due to vague safety guidelines may slow down the growth.
Exoskeleton Market Trends
The Mobile Segment is Expected to Exhibit Significant Growth Opportunities Over the Forecast Period
Mobile exoskeletons are designed to allow free movement of users and are designed with more customer-centric attributes. Factors such as increasing demand for mobile systems for their enhanced mobility and flexibility and improved ergonomic designs of mobile systems are projected to fuel segmental growth over the forecast period. Growing applications of mobile exoskeleton systems in different industry verticals like healthcare and manufacturing are expected to propel market growth over the forecast period.
The improved role of mobile exoskeletons, like lower-limb exoskeletons, in the normal movement of patients is projected to foster the adoption of such exoskeletons, which would boost segmental growth over the forecast period. For instance, according to an article published by Medicine in January 2022, the mobile lower-limb exoskeleton can provide functional exercises and closely resemble normal movement patterns. Thus, such benefits offered by mobile systems are likely to propel their adoption over the coming years.
The increased burden of musculoskeletal disorders like osteoarthritis, spinal cord injuries, and dysplasia has contributed to the increased demand for mobile exoskeletons with enhanced battery backup. For instance, according to an article published by BMC Musculoskeletal Disorders in April 2024, osteoarthritis poses a significant disease burden on people aged 30 to 44 years, and the burden is amid unhealthy lifestyles and obesity.
Thus, the significant burden of osteoarthritis generates the demand for mobile exoskeletons with enhanced battery life for long-lasting support to people while walking, which is expected to boost segmental growth over the coming years.
Several initiatives by companies to enhance their geographic reach are further projected to accelerate segment growth. For instance, in October 2023, Wandercraft, a manufacturer of mobile exoskeletons, started its operations in the United States by launching the mobility exoskeleton Atalante X in partnership with the Kessler Foundation.
Thus, the above-mentioned factors, like the growing demand for mobile exoskeleton systems, the benefits associated with them, and several strategic initiatives undertaken by market participants, are projected to boost segmental growth over the forecast period.
North America is Expected to Hold a Significant Market Position Over the Forecast Period
The key factors driving the North American market are the significant burden of musculoskeletal disorders, the rising geriatric system, and the growing adoption of exoskeleton systems amid higher awareness levels. In addition, rising research activities in the region and several strategic initiatives undertaken by market participants are expected to accelerate market growth over the forecast period.
The significant burden of musculoskeletal disorders across the region is expected to accelerate the adoption of exoskeleton systems, which is projected to accelerate market growth over the forecast period. For instance, according to an article published by Neurotrauma Reports in April 2024, the burden of spinal injuries in polytraumatized patients increased over the years in Mexico, and most of them were among the elderly population. Similarly, according to the May 2024 updated data of the Osteoarthritis (OA) Action Alliance, arthritis is one of the key conditions in the United States, and an estimated 1 in 5 people have arthritis every year. Thus, the increasing burden of musculoskeletal disorders is projected to foster the adoption of exoskeleton systems for assistive movement, supporting regional market growth over the forecast period.
Regional market growth is further expected to be driven by leveraging the role of exoskeleton systems in managing healthcare workflow. For instance, according to an article published by BMC Nursing in May 2024, the integration of exoskeleton systems in nursing departments could improve posture, reduce fatigue and strain, and help improve overall job satisfaction. This is expected to accelerate regional market growth over the forecast period.
Research efforts to develop promising exoskeleton systems for multiple applications are projected to boost regional market growth over the forecast period. For instance, in April 2024, a group of researchers from NC State University’s Department of Mechanical and Aerospace Engineering published a new research paper on pediatric exoskeletons Mechatronics that focused on the application of exoskeletons in pediatrics. Such research activities are expected to facilitate the development of novel exoskeletons to cater to several unmet needs.
Thus, the above-mentioned factors, such as the significant burden of musculoskeletal disorders, the growing uptake of the exoskeleton system, and rising research activities in the region, are projected to boost regional market growth over the forecast period.
Exoskeleton Industry Overview
The market is fragmented and consists of many players globally and regionally. Some of the key players in the market are CYBERDYNE, Rewalk Robotics, BIONIK, and B-Temia. The increasing investments by these players in the development of new and innovative products and the FDA approvals of their products support market growth.
Exoskeleton Market Leaders
-
Rewalk Robotics
-
Bioness Inc.
-
CYBERDYNE INC.
-
BIONIK
-
B-Temia
*Disclaimer: Major Players sorted in no particular order
Exoskeleton Market News
- March 2024: Innophys Co. Ltd commenced the sales of “Muscle Suit Soft-Power” and "Muscle Suit Every" exoskeleton systems in Slovakia and the Czech Republic in March 2024.
- October 2023: SUITX by Ottobock planned to launch the IX BACK AIR exoskeleton system. This system has combined the comfort of soft models with the power of rigid systems.
Global Exoskeleton Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Demand from Healthcare Sector for Robotic Rehabilitation
4.2.2 Advancement in Robotic Technologies
4.2.3 Growing Burden of Musculoskeletal Disorders
4.3 Market Restraints
4.3.1 Risks Involved with Using Exoskeletons Due to Vague Safety Guidelines
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD)
5.1 By Treatment Type
5.1.1 Rehabilitation
5.1.2 Augmentation
5.2 By Body Part Type
5.2.1 Upper Body
5.2.2 Lower Body
5.3 By Product Type
5.3.1 Stationary
5.3.2 Mobile
5.4 By Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 CYBERDYNE INC.
6.1.2 Ekso Bionics
6.1.3 Rewalk Robotics (LIFEWARD)
6.1.4 BIONIK
6.1.5 PARKER HANNIFIN CORP
6.1.6 Bioservo
6.1.7 Gogoa Mobility Robots
6.1.8 Rehab-Robotics Company Limited
6.1.9 Bioness Inc. (Bioventus.)
6.1.10 B-Temia
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Exoskeleton Industry Segmentation
As per the scope of the report, exoskeletons are the external skeletons that support and protect the body in contrast to the internal skeleton (endoskeleton). These are wearable machines that enable limb movement with amplified strength and enhance the performance of human tasks.
The exoskeleton market is segmented by treatment type, body part type, product type, and geography. By treatment type, the market is segmented into rehabilitation and augmentation. By body part type, the market is segmented into upper body and lower body. By product type, the market is segmented into stationary and mobile. The report also covers the market sizes and forecasts in major countries across different regions. For each segment, the market size is provided in terms of value (USD).
| By Treatment Type | |
| Rehabilitation | |
| Augmentation |
| By Body Part Type | |
| Upper Body | |
| Lower Body |
| By Product Type | |
| Stationary | |
| Mobile |
| By Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Global Exoskeleton Market Research Faqs
How big is the Global Exoskeleton Market?
The Global Exoskeleton Market size is expected to reach USD 0.82 billion in 2024 and grow at a CAGR of 15.32% to reach USD 2.79 billion by 2029.
What is the current Global Exoskeleton Market size?
In 2024, the Global Exoskeleton Market size is expected to reach USD 0.82 billion.
Who are the key players in Global Exoskeleton Market?
Rewalk Robotics, Bioness Inc., CYBERDYNE INC., BIONIK and B-Temia are the major companies operating in the Global Exoskeleton Market.
Which is the fastest growing region in Global Exoskeleton Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Exoskeleton Market?
In 2024, the North America accounts for the largest market share in Global Exoskeleton Market.
What years does this Global Exoskeleton Market cover, and what was the market size in 2023?
In 2023, the Global Exoskeleton Market size was estimated at USD 0.69 billion. The report covers the Global Exoskeleton Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Exoskeleton Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Global Exoskeleton Industry Report
Statistics for the 2024 Medical Exoskeleton market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Medical Exoskeleton analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
